Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Novavax Inc. (NVAX)

8.165   0.445 (5.76%) 02-24 16:00
Open: 8.305 Pre. Close: 7.72
High: 8.5 Low: 7.93
Volume: 4,978,245 Market Cap: 262M
Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.504 - 8.555 8.555 - 8.605
Low: 7.814 - 7.872 7.872 - 7.927
Close: 8.07 - 8.156 8.156 - 8.239

Technical analysis

as of: 2020-02-24 4:45:56 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 11.67     One year: 13.63
Support: Support1: 6.76    Support2: 4.76
Resistance: Resistance1: 9.99    Resistance2: 11.67
Pivot: 7.38
Moving Average: MA(5): 7.95     MA(20): 7.39
MA(100): 5.11     MA(250): 6.59
MACD: MACD(12,26): 0.57     Signal(9): 0.58
Stochastic oscillator: %K(14,3): 82.86     %D(3): 85.09
RSI: RSI(14): 61.76
52-week: High: 43.40  Low: 3.54  Change(%): -80.0
Average Vol(K): 3-Month: 431956  10-Days: 323141

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVAX has closed below upper band by 13.1%. Bollinger Bands are 1.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 24 Feb 2020 13:31:00 +0000
Why Inovio Pharmaceuticals and Novavax Shares Are Exploding Higher Today

Sat, 22 Feb 2020 15:00:00 +0000
These 2 Stocks Could Be 2020's Best Profit Opportunities

Tue, 18 Feb 2020 18:14:00 +0000
Sanofi Gets Backing From U.S. Government to Develop a COVID-19 Vaccine

Mon, 17 Feb 2020 14:57:00 +0000
6 Healthcare Stocks That Could Make You Filthy Rich

Wed, 12 Feb 2020 13:11:53 +0000
Pandemic Fears Not Enough to Buy Inovio Stock

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 32.12
Shares Float (M) 26.30
% Held by Insiders 0.64
% Held by Institutions 22.41
Shares Short (K) 4960
Shares Short P. Month (K)

Stock Financials

EPS -6.870
Book Value (p.s.) -7.440
PEG Ratio
Profit Margin
Operating Margin -922.83
Return on Assets (ttm) -44.4
Return on Equity (ttm)
Qtrly Rev. Growth -67.6
Gross Profit (p.s.) -4.343
Sales Per Share
EBITDA (p.s.) -4.380
Qtrly Earnings Growth
Operating Cash Flow (M) -158.15
Levered Free Cash Flow (M) -88.21

Stock Valuations

P/E -1.19
P/E Growth Ratio 0.06
P/BV -1.10
P/S 11.18
P/CF -1.66

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-05-09
Last Split Ratio 0.05
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.